1. Article | 2020.10.14

   Covid-19: A vaccine candidate using a lentiviral vector

   This vaccine candidate for the SARS-CoV-2 virus, designed for nasal administration, demonstrated intense protection and extremely high production of antibodies and cytotoxic cell responses in preclinical trials.

2. Article | 2020.10.14

   Covid-19: a DNA vaccine

   Of all the vaccines developed at the Institut Pasteur for SARS-CoV-2 (the virus that causes COVID-19), the DNA vaccine undoubtedly involves the most novel approach, since no vaccine using this technology has yet been commercialized* (for humans).

3. News | 2020.10.17

   Have I seen this before? Exploring the formation of distinct memories

   How do we form and use distinct memories of resembling events? Scientists at the Institut Pasteur (Paris) have combined imaging and behavioral recording techniques to measure the activity of neurons in the hippocampus of mice. According to their observations, the input region of the hippocampus detects small changes between familiar and novel environments, while the output region then weights...

4. News | 2020.10.15

   A Center for Research in Emerging Infectious Diseases, funded by NIH at the Institut Pasteur in Paris

   The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded 11 grants to establish the Centers for Research in Emerging Infectious Diseases (CREID), including a coordinating center. One of those centers, and the sole center coordinated by a non-American organization, is the Pasteur International Center for Research on Emerging...

5. Document de presse | 2020.10.16

   Team of international scientists identify common vulnerabilities across SARS-CoV-2, SARS-CoV-1 and MERS coronaviruses

   Driven by Molecular Insights, Massive Analysis of Medical Records from ~740,000 SARS-CoV-2 Patients Reveal Treatment Regimens for Current, and Potential Future, Viral Pandemics. Published on October 15, 2020, in Science. In a study published online in Science, an international team of almost 200 researchers from 14 leading institutions in six countries, including France with the...

6. News | 2020.10.21

   Cholera: researchers track the origin of epidemics in Europe since 1970

   Thanks to the collection of cholera vibrio strains from the National Reference Centre for Vibrio and Cholera (hosted by the Enteric Bacterial Pathogens Unit at the Institut Pasteur in Paris) and in collaboration with scientists from the Cantacuzino Institute (Bucharest, Romania) and the Public Health Agency of Canada, a retrospective analysis of the latest cholera epidemics in Europe, related to...

7. News | 2020.10.21

   Cholera: study of the strain responsible for the 2018-2019 epidemic in Zimbabwe

   Between September 2018 and March 2019, a cholera epidemic took place in Zimbabwe, causing 10 000 cases and 69 deaths. The Enteric Bacterial Pathogens Unit at the Institut Pasteur (Paris) took part to the study of a strain of Vibrio cholerae (Vibrio cholerae O1) responsible for this epidemic. This study was made with scientists from the National Institute for Communicable Diseases of South...

8. News | 2020.10.27

   Antibiotic resistance: the Institut Pasteur's microbiological expertise and unique collection of resistant strains contribute to research on group A streptogramins

   The Institut Pasteur's outstanding collection of bacterial strains has played a key role in research at the University of California. The collection was used in a study exploring how the modification of group A streptogramins, a class of antibiotics discovered and isolated in France in the 1960s, can restore their efficacy by enabling them to overcome the resistance mechanisms employed by the...

9. News | 2020.11.02

   New Edition Of The Free On-Line Mooc Tuberculosis

   Tuberculosis (TB) remains one of the ten leading causes of death worldwide and the biggest killer among infectious diseases, surpassing even AIDS and malaria. Although it is hoped that TB can be eliminated within the next couple of decades, the incidence is currently falling by only 1.5% per year. Each year there are about 10 million new cases of TB and a half a million of these are multi-drug...

10. Document de presse | 2020.11.03

    Number of Covid-19 deaths in the under-65s: a more reliable indicator for assessing infection rates in populations

    Simply comparing the total number of deaths across countries may provide a misleading representation of the underlying level of transmission of SARS-CoV-2, the virus that causes COVID-19, because of large differences in reported COVID-19 death rates in elderly populations in different countries.The research conducted by the University of Cambridge, the Institut Pasteur and the CNRS, published...

Pages